📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Changes in the Rate of Leucine-Rich Glioma-Inactivated 1 Seropositivity During the COVID-19 Lockdown (2023)

First Author: Handel A

Attributed to: Mapping T cell antigen-specificity in LGI1 antibody encephalitis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1001/jamaneurol.2022.5346

PubMed Identifier: 36780183

Publication URI: http://europepmc.org/abstract/MED/36780183

Type: Journal Article/Review

Parent Publication: JAMA Neurology

Issue: 4

ISSN: 2168-6149